Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OPTIRAY vs OSIMERTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OPTIRAY vs OSIMERTINIB: Safety Overview

Metric OPTIRAY OSIMERTINIB
Total FAERS Reports 103 27,750
Deaths Reported 2 12,456
Death Rate 1.9% 44.9%
Hospitalizations 18 5,277
Average Patient Age 54.0 yrs 68.2 yrs
% Female Patients N/A 66.0%
FDA Approval Date N/A Nov 13, 2015
Manufacturer N/A AstraZeneca Pharmaceuticals LP
Route N/A ORAL
Marketing Status N/A Prescription